Treatment of Paget’s disease of bone with alendronate
- 22 April 1999
- Vol. 24 (5) , 59S-61S
- https://doi.org/10.1016/s8756-3282(99)00063-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Risedronate in the Treatment of Paget's Disease of Bone: An Open Label, Multicenter StudyJournal of Bone and Mineral Research, 1998
- MECHANISMS OF ACTION OF BISPHOSPHONATESAnnual Review of Pharmacology and Toxicology, 1998
- Bisphosphonates: Mechanisms of ActionEndocrine Reviews, 1998
- The Management of Paget's Disease of BoneNew England Journal of Medicine, 1997
- Esophagitis Associated with the Use of AlendronateNew England Journal of Medicine, 1996
- Comparative study of alendronate versus etidronate for the treatment of Paget's disease of boneJournal of Clinical Endocrinology & Metabolism, 1996
- Determinants of remission of paget's disease of boneJournal of Bone and Mineral Research, 1993
- Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APDThe British Journal of Radiology, 1987
- Clinical and biochemical effects of EHDP in Paget's disease of bone: Patterns of response to initial treatment and to long-term therapyMetabolic Bone Disease and Related Research, 1981
- Radiological evidence of a dose-related response to long-term treatment of Paget's disease with human calcitoninThe British Journal of Radiology, 1974